Skip to content
Chronic Lung Diseases
  • HOME
  • NEWS
  • RESOURCES
    • ASTHMA
    • COPD
    • PULMONARY FIBROSIS
    • SMOKE FREE
    • INHALED MEDICATION
    • BEING ACTIVE
    • CHRONIC COUGH
    • COVID-19
    • PULMONARY HYPERTENSION
  • PODCAST
    • SEASON 3: COPD​
    • SEASON 4: COVID-19
    • SEASON 5: AATD
    • SEASON 6: PAH
    • SEASON 7: RESPIRATORY INFECTIONS
    • ALL EPISODES
  • TOOLS
    • Action Plans
      • COPD Action Plan
      • Severe Asthma Action Plan
    • Reports
      • Pulmonary Arterial Hypertension Report – Nov 2025
      • Pneumococcal Vaccination Report – Jan 2025
      • IDEAL Plan – Feb 2025
      • Disease X Preparedness Report – Nov 2024
  • ABOUT US
  • Sign Up
  • Login
  • FR
Menu Close
News
  • All
  • AATD
  • Being Active
  • Chronic Cough
  • COPD
  • COVID-19
  • Inhaled Medication
  • Pulmonary Fibrosis
  • Smoke Free
  • Pulmonary Hypertension
  • Podcast
  • All
  • AATD
  • Being Active
  • Chronic Cough
  • COPD
  • COVID-19
  • Inhaled Medication
  • Pulmonary Fibrosis
  • Smoke Free
  • Pulmonary Hypertension
  • Podcast
March 26, 2026

Learn how chronic disease, social determinants, and healthcare access influence respiratory infection outcomes in Indigenous populations in Canada.

How Historical Trauma and Health Inequities Shape Respiratory Outcomes in Indigenous Communities

March 13, 2026

Explore COVID-19 and respiratory infection challenges in Indigenous communities in Canada. Learn about barriers, resilience, and practical healthcare insights.

Understanding Healthcare Gaps for Indigenous Communities Facing Respiratory Disease

March 3, 2026

Alpha-1 family testing helps identify inherited risk early. Learn how simple blood screening can protect lung and liver health.

Alpha-1 Family Testing: Why It Matters

February 16, 2026

Augmentation therapy is the only Alpha-1 treatment that targets the deficiency. Learn why timing matters, what it does, and what happens next.

Augmentation Therapy: Why Waiting After Alpha-1 Hurts

February 3, 2026

Alpha-1 diagnosis explains genetic COPD risk. Learn what Alpha-1 is, how it damages lungs, and why early testing protects long-term lung health.

Alpha-1 Diagnosis: What It Is and Why Timing Matters

January 26, 2026

Alpha-1 testing can uncover a genetic cause of COPD. Learn who to test, how the blood test works, and what a low level means for next steps.

Why every person with COPD should be tested for alpha-1 antitrypsin deficiency

AN INITIATIVE OF

  • Home
  • News
  • Resources
  • Podcast
  • About us
  • Terms of Use
  • Privacy Policy
  • Contact-us
Copyright - Respiplus 2020
Close Menu
  • LOGIN
  • Chronic Lung Diseases: Resources for COPD, Asthma, and more
  • News
  • Resources
  • Le Podcast eXpand
  • About us
  • Contact
  • FR